ADAK 2023 ADAK vs Betty Chelangat

In August 2023 the Anti-Doping Agency of Kenya (ADAK) reported and anti-doping rule violation against the Athlete Betty Chelangat after her sample tested positive for the prohibited substance Methasterone.

Following notification the Athlete timely admitted the violation, waived her right for a hearing, accepted a provisional suspension and the sanction proposed by ADAK.

ADAK deems that the Athlete's violation was intentional and determines that she shall receive a 1 year reduction for her timely admission of the anti-doping rule violation.

Therefore ADAK decides on 14 December 2023 to impose a 3 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 12 September 2023.

Original document

Parameters

Legal Source
National Decisions
Settlement
Date
14 December 2023
Original Source
Anti-Doping Agency of Kenya (ADAK)
Country
Kenya
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acceptance of sanction
Period of ineligibility
Prompt / Timely Admission
Waiver of "right to be heard"
Sport/IFs
Athletics (WA) - World Athletics
Other organisations
Anti-Doping Agency of Kenya (ADAK)
Doping classes
S1. Anabolic Agents
Substances
Methasterone (17β-hydroxy-2α,17α-dimethyl-5α-androstan-3-one)
Document type
Pdf file
Date generated
9 January 2024
Date of last modification
23 January 2024
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin